Treatment of Severe Refractory Thrombocytopenia in Brucellosis with Eltrombopag: A Case Report

Pediatr Infect Dis J. 2022 Aug 1;41(8):e332-e335. doi: 10.1097/INF.0000000000003555. Epub 2022 Jul 13.

Abstract

Brucellosis is a zoonotic disease. Severe refractory thrombocytopenia caused by brucellosis is very rare and easily misdiagnosed. We reported a 5-year-old girl who developed severe refractory thrombocytopenia secondary to brucellosis. The first-line treatment including corticosteroids and intravenous immunoglobulin did not elevate her platelets, but eltrombopag worked well and her platelet count recovered rapidly.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzoates / therapeutic use
  • Brucellosis* / complications
  • Brucellosis* / diagnosis
  • Brucellosis* / drug therapy
  • Child, Preschool
  • Female
  • Humans
  • Hydrazines / therapeutic use
  • Pyrazoles
  • Thrombocytopenia* / complications
  • Thrombocytopenia* / drug therapy

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • eltrombopag